Clinical Trials Logo

Filter by:
NCT ID: NCT00299403 Completed - Depressive Disorder Clinical Trials

The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT

Start date: May 2002
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the present study is to compare the antidepressant effect of electroconvulsive therapy ( ECT) with that of low frequency repetitive transcranial magnetic stimulation of the right prefrontal cortex. In the same study we investigate the value of saliva cortisol as a predictor of treatment outcome.

NCT ID: NCT00299325 Completed - Metabolic Syndrome Clinical Trials

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

VICTORIA
Start date: March 2006
Phase: Phase 3
Study type: Interventional

Primary objective: To assess the effect of rimonabant on visceral fat area over a period of 12 months when prescribed with a mild hypocaloric diet in abdominally obese patients with metabolic syndrome Secondary objectives: - To assess the effect of rimonabant over a period of 12 months on: - Liver fat content using CT scan (Computed Tomography scan) - Anthropometric measures (weight, waist circumference, body composition using Dual Energy X-ray Absorptiometry (DEXA)) - Lipid, lipoprotein profile - Glycemia, insulinemia and HbA1c - Adipokines, inflammatory and hemostatic markers - To evaluate the percentage of patients with metabolic syndrome at 12 months - To evaluate the safety and tolerability of rimonabant in these patients In four selected US sites the effect of rimonabant at 12 months will be also assessed on: - Basal lipolysis and insulin suppressed lipolysis (euglycemic hyperinsulinemic clamp). - Resting metabolic rate and substrate oxidation at rest using indirect calorimetry. - Adipose tissue histology and expression of genes involved in glucose and lipid metabolism (superficial adipose tissue biopsy).

NCT ID: NCT00299117 Completed - Breast Cancer Clinical Trials

Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery

Start date: April 2006
Phase: N/A
Study type: Interventional

The primary purpose of this study is to examine the effect of a brief preoperative smoking intervention on postoperative complications in women undergoing breast cancer surgery. Secondary purposes are to examine long-term smoking cessation rates and experienced stress and nicotine withdrawal symptoms during the smoking cessation period.

NCT ID: NCT00299013 Completed - Ulcerative Colitis Clinical Trials

Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a novel dosage form of a prednisolone ester, called COLAL-PRED®, is useful in the treatment of ulcerative colitis.

NCT ID: NCT00298688 Completed - Clinical trials for Small Cell Lung Cancer

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

Start date: September 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the disease control rate at trial closure and after the first stage of the study in patients with relapsed or refractory SCLC and measurable disease treated with gefitinib

NCT ID: NCT00296400 Completed - Hyperlipidemia Clinical Trials

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease

PLANET II
Start date: February 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in non-diabetes with moderate proteinuria and hypercholesterolaemia.

NCT ID: NCT00296374 Completed - Diabetes Mellitus Clinical Trials

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

PLANET 1
Start date: February 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

NCT ID: NCT00296153 Completed - Clinical trials for Ischemic Heart Disease

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Start date: February 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of Omacor 4g/day on blood lipid parameters and on the function and stiffness of blood vessels in HIV infected patients on Antiretroviral Therapy (HAART)

NCT ID: NCT00295594 Completed - Clinical trials for Liver Transplantation

Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.

MARSILEA
Start date: March 2005
Phase: Phase 3
Study type: Interventional

To compare the efficacy and safety of two regimens containing tacrolimus and minimal steroids together with either monoclonal anti-IL2R antibodies (daclizumab) or mycophenolate mofetil.

NCT ID: NCT00293514 Completed - Clinical trials for Intraoperative Complications

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the sealing efficacy and safety of TachoSil® (hereafter referred to as TachoSil) versus standard surgical treatment as the secondary management of intra-operative pulmonary air leakage after a lobectomy in subjects with lung malignancies with or without metastases.